dahuder mj

DAHUDER Medical Journal

2791-9250

DAHUDER

10.56016/dahudermj.1886504

Internal Diseases

İç Hastalıkları

Frequency of Microalbuminuria in Stages of Chronic Kidney Disease

https://orcid.org/0009-0008-2437-0512

Coşkun

Mehmet

SINCAN TRAINING AND RESEARCH HOSPITAL

https://orcid.org/0000-0001-6041-3817

Araç

Eşref

DICLE UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE Yılmaz

Mehmet Emin

DICLE UNIVERSITY

Advanced Online Publication 44 50 02 15 2026 04 10 2026

2021

DAHUDER Medical Journal

Objective: To investigate the frequency of microalbuminuria and associated risk factors across the stages of chronic kidney disease (CKD).Methods: This cross-sectional study included 200 patients aged 16-85 who applied to the Internal Medicine Outpatient Clinic between November 2009 and February 2010. Demographic data and blood pressure were recorded. Biochemical parameters, along with 24-hour urinary protein and albumin excretion, were measured. CKD staging was performed according to GFR calculated using the MDRD formula.Results: Of the patients, 64% were female. The most common etiology was undetermined (58%). Among identified causes, diabetes mellitus and hypertension were primary. As the CKD stage progressed, proteinuria and albuminuria levels increased significantly (p<0.001). The frequency of microalbuminuria was 23.1% in Stage 1 and reached 80% in Stage 5. Significant associations were found between CKD stages and blood pressure, urea, creatinine, potassium, calcium, hemoglobin, and CRP levels (p<0.05). Proteinuria and albuminuria showed a negative correlation with GFR and a positive correlation with CRP (p<0.001).Conclusion: Microalbuminuria appears from the early stages of CKD, and its frequency increases as the disease progresses. Hypertension and inflammation (elevated CRP) are independent risk factors associated with microalbuminuria. Screening CKD patients for microalbuminuria from the early stages is crucial for slowing disease progression.

Chronic kidney disease Microalbuminuria Proteinuria CRP Hypertension

1. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis. 1996;27(6):765- 75. doi:10.1016/S0272-6386(96)90512-0.

2. Hirschberg R, Wang S. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens. 2005;14(1):43-52. doi:10.1097/00041552-200501000-00008.

3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;319(8287):1430-2. doi:10.1016/S0140- 6736(82)92450-3.

4. Kaplan NM. Microalbuminuria: a risk factor for vascular and renal complications of hypertension. Am J Med. 1992;92(4-Suppl 2):S9-12. doi:10.1016/0002- 9343(92)90141-W.

5. Winocour PH. Microalbuminuria. BMJ. 1992;304(6836):1196-7. doi:10.1136/bmj.304.6836.1196.

6. Erdmann E. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int J Cardiol. 2006;107(2):147-53. doi:10.1016/j.ijcard.2005.03.053.

7. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157(13):1413-8. doi:10.1001/ archinte.1997.00440340025002.

8. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310(6):356-60. doi:10.1056/ NEJM198402093100605.

9. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int. 2006;69(7):1189-97. doi:10.1038/ sj.ki.5000212.

10. Gansevoort RT, de Zeeuw D, de Jong PE. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant. 1995;10(4):497-504. doi:10.1093/ndt/10.4.497.

11. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93(1-2):71-81. doi:10.1016/0021-9150(92)90201-Q.

12. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif. 2000;18(3):183-90. doi:10.1159/000014417.

13. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, et al. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron. 2002;91(4):594-600. doi:10.1159/000065018.

14. Gomes MB, Nogueira VG. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract. 2004;66(1):31-9. doi:10.1016/j. diabres.2004.02.009.

15. Onat A, Sansoy V, Soydan İ, Tokgözoğlu L, Adalet K. TEKHARF, on iki yıllık izleme deneyimine göre Türk erişkinlerinde kalp sağlığı. İstanbul: Türkiye; 2003. p. 12-4.

16. Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens. 1998;11(4):430-8. doi:10.1016/S0895-7061(97)00498-6.

17. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002;13(2):504-10. doi:10.1681/ASN.V132504.

18. Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW. Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes. 1989;38(12):1602-10. doi:10.2337/diab.38.12.1602.